InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: Skiluc post# 94883

Monday, 10/25/2021 4:41:08 PM

Monday, October 25, 2021 4:41:08 PM

Post# of 118402
Whatever happened to Koos' Checkpoint Immunology Inc that was supposed to usher in and commercialize NR2F6?


Oh wait, that went belly up too!

LOL. Nr2F6 was and still is a bust!

Koos thinks that spending 25K to try and get some type of interest in Nr2F6 will most likely be more money wasted.

Remember, he left Regen back in Jan of 2020 because Regen was a bust. It still is a bust.

https://www.prnewswire.com/news-releases/regen-biopharma-inc-licenses-nr2f6-technology-for-cancer-treatment-and-autoimmune-disorders-to-checkpoint-immunology-inc-615203633.html

FACTS are stubborn things